3645 — Medical Net Income Statement
0.000.00%
- ¥3bn
- ¥3bn
- ¥5bn
- 64
- 36
- 38
- 42
Annual income statement for Medical Net, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
2020 May 31st | C2021 May 31st | R2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,918 | 2,905 | 3,746 | 4,501 | 5,252 |
Cost of Revenue | |||||
Gross Profit | 972 | 1,178 | 1,460 | 1,781 | 1,841 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,811 | 2,652 | 3,216 | 4,305 | 5,129 |
Operating Profit | 106 | 253 | 529 | 196 | 123 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 104 | 254 | 534 | 251 | 153 |
Provision for Income Taxes | |||||
Net Income After Taxes | 83.5 | 138 | 396 | 109 | 26.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 79.3 | 130 | 380 | 116 | 5.96 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 79.3 | 130 | 380 | 116 | 5.96 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.5 | 22 | 38.1 | 26.9 | 16.6 |
Dividends per Share | |||||
Special Dividends per Share |